| Literature DB >> 35702996 |
Wei Du1,2, Christian Adkisson2,3,4, Xianjun Ye2,5,6,7, Camille L Duran2,5,7, Benson Chellakkan Selvanesan8, Claudia Gravekamp8, Maja H Oktay2,5,7, John C McAuliffe4,5,6, John S Condeelis2,3,4,5,6, Nicole C Panarelli5,6,7, Robert J Norgard9, Yogev Sela9, Ben Z Stanger9, David Entenberg2,5,6,7.
Abstract
Pancreatitis and pancreatic ductal adenocarcinoma (PDAC) are grave illnesses with high levels of morbidity and mortality. Intravital imaging (IVI) is a powerful technique for visualizing physiological processes in both health and disease. However, the application of IVI to the murine pancreas presents significant challenges, as it is a deep, compliant, visceral organ that is difficult to access, easily damaged and susceptible to motion artefacts. Existing imaging windows for stabilizing the pancreas during IVI have unfortunately shown poor stability for time-lapsed imaging on the minutes to hours scale, or are unable to accommodate both the healthy and tumour-bearing pancreata. To address these issues, we developed an improved stabilized window for intravital imaging of the pancreas (SWIP), which can be applied to not only the healthy pancreas but also to solid tumours like PDAC. Here, we validate the SWIP and use it to visualize a variety of processes for the first time, including (1) single-cell dynamics within the healthy pancreas, (2) transformation from healthy pancreas to acute pancreatitis induced by cerulein, and (3) the physiology of PDAC in both autochthonous and orthotopically injected models. SWIP can not only improve the imaging stability but also expand the application of IVI in both benign and malignant pancreas diseases.Entities:
Keywords: cerulein; intravital imaging; pancreatic ductal adenocarcinoma; pancreatitis
Mesh:
Year: 2022 PMID: 35702996 PMCID: PMC9198798 DOI: 10.1098/rsob.210273
Source DB: PubMed Journal: Open Biol ISSN: 2046-2441 Impact factor: 7.124
Figure 1Overview of the stabilized window for imaging of the pancreas (SWIP) and SWIP surgical protocol. (a) Picture of the SWIP. Three lines etched on the frame allow the use of microcartography to relocate regions of interest during serial imaging. (b) Cartoon demonstrating the cross stitch ‘basket’ that stabilizes the pancreas tissue laterally and axially. (c–g) Summary of the steps of the SWIP surgical procedure. (c) An incision is made in the upper left quadrant of abdomen through the skin and abdominal wall and the pancreas exposed (dashed outline). (d) Cross stitch is placed over the pancreas and one end is secured to the abdominal muscle with a square knot. (e) The pancreas is gently laid on top of the cross stitch. (f) A purse-string suture is placed through the skin and abdominal wall around the incision. (g) The window frame is fitted in the incision with both the skin and abdominal wall within the frame's groove. The purse string suture is tightened and the free end of cross stitch pulled gently taut and tied in the groove. Finally, adhesive is applied to the recess of the window and cover glass affixed in place. (h) View of the mouse post window implantation.
Figure 2The SWIP greatly improves stability of imaging. (a) Stills from within the first 72′ of a time-lapse movie of the pancreas imaged through the SWIP. Some axial but very little lateral drift can be observed. See electronic supplementary material, movie 3. (b) Continued time-lapsed imaging after 72′ shows a high level of axial and lateral stability. See electronic supplementary material, movie 4. (c–e) Comparison of the lateral stability of each of the pancreas imaging windows during the first hour of imaging for the (c) abdominal imaging window (AIW), (d) pancreas imaging window (PIW), and (e) stabilized window for intravital imaging of the pancreas (SWIP). (f–h) Comparison of the lateral stability of each of the pancreas imaging during the subsequent 150 min for the (f) AIW, (g) PIW, and (h) SWIP. Insets are zoomed in views of the corresponding plots. (i–k) Comparison of the axial stability of each of the pancreas imaging windows for the first 120 min of imaging for the (i) AIW, (j) PIW and (k) SWIP.
Figure 3Cellular and subcellular dynamics in healthy pancreas. (a) In the healthy pancreas, motile acinar cells can be observed appearing (white arrows), disappearing (yellow arrows) and translocating to adjacent locations (red arrows, initial position of cell marked by red dashed outline). See electronic supplementary material, movie S7. (b) Subcellular structures such as nuclei are clearly visible (yellow arrow heads). Other subcellular structures that exclude the cyan fluorescent protein can be observed to appear (white arrows), disappear (yellow arrows), and translocate (red arrows, initial position marked by red dashed outline) over time. See electronic supplementary material, movie S8.
Figure 4Cerulein treatment induces morphological changes. (a) Serial IVI of the pancreas over two consecutive days in mice treated with PBS. (b) Comparison of IVI and H&E images of healthy mouse (left and centre) and H&E image of the human pancreas (right) showing similar cellular morphology including pyramidal contours, round basally oriented nuclei (white arrowheads), and abundant granular cytoplasm. (c) Serial IVI of the pancreas over two consecutive days in mice treated with cerulein. Cell rounding (red arrows) is evident by 24 h after the first injection of cerulein. Cell shrinkage, presenting as intralobular space widening (red arrowheads) can also be observed. (d) H&E stained tissue sections from PBS and cerulein treated mice showing similar morphological changes of cell rounding (red arrow) and shrinkage (red arrowhead) within the cerulein treated pancreas. (e) IVI of cerulein-induced acute pancreatitis. Several features of pancreatitis appear visible including cell rounding (red arrows), apoptotic bodies (yellow arrows) and autolysosomes (yellow circle). Autophagic vacuolization in pancreatic cells could also be observed as time went by (white arrows). (f) Similar morphological changes can be observed in H&E sections of pancreas taken from identically treated mice, including cell rounding (red arrows), cell fragmentation or apoptotic bodies (yellow arrows), autolysosomes (yellow circle) and autophagic vacuoles (white arrows). (g) The changes observed in the mice reflect those observed in pancreatitis in human patients. These include cell rounding (red arrows), apoptotic bodies (yellow arrows), and autophagic vacuoles (white arrows). (h) Stills from a time-lapsed IVI movie showing the process of cell apoptosis due to acute pancreatitis induced by cerulein. Cytoplasmic CFP signal intensity can be seen to decreased gradually (orange arrows), then condense into separate apoptotic bodies (red arrows). See electronic supplementary material, movie S9. (i) Tissues taken from PBS- (left) and cerulein-treated (right) mice and stained for CFP (green), cleaved caspase-3 (CC3, red), a marker of cell apoptosis and DAPI (blue).
Figure 5Application of the SWIP to orthotopically injected tumor mouse models. (a) Large-volume high-resolution intravital imaging (LVHR-IVI) captures time-lapse movies of large volumes of tumor tissue at single cell resolution and in real time. Left is a 4 × 4 mosaic covering 1.1 × 1.1 mm. Stills from simultaneously acquired sub-regions reveal single cell dynamics with subcellular resolution. See electronic supplementary material, movie S10. (b) An example of tumour cells undergoing collective migration. See electronic supplementary material, movie S11. (c) Examples of single cell migration (yellow and red arrows). Green = Dendra2 expressing tumour cells, Blue = CFP expressing macrophages. See electronic supplementary material, movie S12.
Figure 6Application of the SWIP to spontaneously forming tumours in transgenic mouse models of cancer. (a) Still from a time-lapsed intravital imaging (IVI) movie of the pancreas in the transgenic mouse model of pancreatic ductal adenocarcinoma (PDAC). See electronic supplementary material, movie S13. (b) Stills from a time-lapsed IVI movie showing two transient vascular opening events (red and orange arrows). Red circle indicates area where signal intensity of the red channel (extravascular of 155-kD tetramethyl-rhodamine labeled dextran) was quantified. See electronic supplementary material, movie S12. (c) Plot of the signal intensity (region outlined by red circle in (b)) over time showing the dynamics of the transient vascular opening events. Red and orange arrows indicate the peaks of the first and second vascular opening events, respectively.